Literature DB >> 12165092

Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection.

L Shen1, Z S Zhang, H W Wu, R E Weir, Z W Xie, L S Hu, S Z Chen, M J Ji, C Su, Y Zhang, Q D Bickle, S N Cousens, M G Taylor, G L Wu.   

Abstract

Schistosome antigen-driven cytokine responses and antischistosome antibody levels of residents of a Schistosoma japonicum endemic island in Poyang Lake, Jiangxi Province were studied before and 45 days after treatment with praziquantel. IL-4, IL-5, IL-10 and INF-gamma were all detected in the supernatants of whole-blood cultures after stimulation with schistosome soluble egg antigen (SEA) and soluble worm antigen preparation (SWAP). The percentages of subjects producing detectable amounts of each cytokine assayed were higher in the group who were negative by stool examination at the start of the study than in those who were initially stool positive. After praziquantel treatment the percentages of subjects producing both type I and type II cytokines increased. This suggests that the production of both types of cytokine was down-regulated in the presence of live, egg-laying S. japonicum adult worms but that this was reversible by treatment. In contrast, the antibody studies showed higher levels of SWAP and SEA-specific antibodies (IgE, total IgG, IgG4, IgM) in subjects who were originally stool-positive than in those who were stool-negative. After treatment specific IgE responses were elevated, but total IgG and IgG4 anti-SEA and IgM anti-SWAP antibody levels all fell significantly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165092      PMCID: PMC1906450          DOI: 10.1046/j.1365-2249.2002.01914.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults.

Authors:  J L Grogan; P G Kremsner; G J van Dam; W Metzger; B Mordmüller; A M Deelder; M Yazdanbakhsh
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

2.  Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. III. Immunity and longitudinal studies of in vitro responsiveness after treatment.

Authors:  D G Colley; I S Barsoum; H S Dahawi; F Gamil; M Habib; M A el Alamy
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

3.  The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil.

Authors:  R Correa-Oliveira; E J Pearce; G C Oliveira; D B Golgher; N Katz; L G Bahia; O S Carvalho; G Gazzinelli; A Sher
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Nov-Dec       Impact factor: 2.184

4.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.

Authors:  D W Dunne; A E Butterworth; A J Fulford; H C Kariuki; J G Langley; J H Ouma; A Capron; R J Pierce; R F Sturrock
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

5.  Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity.

Authors:  R E Weir; A R Morgan; W J Britton; C R Butlin; H M Dockrell
Journal:  J Immunol Methods       Date:  1994-11-10       Impact factor: 2.303

6.  Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy.

Authors:  C E Demeure; P Rihet; L Abel; M Ouattara; A Bourgois; A J Dessein
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

7.  Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.

Authors:  M Roberts; A E Butterworth; G Kimani; T Kamau; A J Fulford; D W Dunne; J H Ouma; R F Sturrock
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium.

Authors:  P Hagan; U J Blumenthal; D Dunn; A J Simpson; H A Wilkins
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

9.  Cell-mediated immune assay in children with Schistosoma haematobium infection and the effect of niridazole therapy.

Authors:  E Abdel-Salam; G I Higashi; K A Kamal; S Ishaac
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

10.  Immune responses and immunoregulation in relation to human schistosomiasis in Egypt. I. Effect of treatment on in vitro cellular responsiveness.

Authors:  I S Barsoum; F M Gamil; M A Al-Khafif; R M Ramzy; M A El Alamy; D G Colley
Journal:  Am J Trop Med Hyg       Date:  1982-11       Impact factor: 2.345

View more
  4 in total

1.  Familial aggregation of human infection with Schistosoma japonicum in the Poyang Lake region, China.

Authors:  Magda K Ellis; Yuesheng Li; Zhu Rong; Honggen Chen; Donald P McManus
Journal:  Int J Parasitol       Date:  2005-10-13       Impact factor: 3.981

2.  Development of a rapid dipstick with latex immunochromatographic assay (DLIA) for diagnosis of schistosomiasis japonica.

Authors:  Li-Ling Yu; Jian-Zu Ding; Li-Yong Wen; Di Lou; Xiao-Lan Yan; Li-Jun Lin; Shao-Hong Lu; Dan-Dan Lin; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2011-08-09       Impact factor: 3.876

Review 3.  Immunology of human schistosomiasis.

Authors:  D G Colley; W E Secor
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

4.  IL-33 Contributes to Schistosoma japonicum-induced Hepatic Pathology through Induction of M2 Macrophages.

Authors:  Hui Peng; Qixian Zhang; Xiaojuan Li; Zhen Liu; Jia Shen; Rui Sun; Jie Wei; Jia Zhao; Xiaoying Wu; Feng Feng; Shuping Zhong; Xi Sun; Zhongdao Wu
Journal:  Sci Rep       Date:  2016-07-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.